BioSpace News Archive

Ventech Solutions, Inc. is proud to have achieved several industry-leading certifications including CMMI® Institute’s Capability Maturity Model® Integration (CMMI) Maturity Level 3 for Development and Services,

Kootenai Health, a regional medical center in northern Idaho, has partnered with Vosaic to more effectively perform simulations to improve staff readiness and comprehensive patient care.

As previously disclosed, Select Medical Holdings Corporation (“Select Medical”) (NYSE: SEM) is currently in discussions with its lenders regarding a proposed refinancing of certain of its outstanding indebtedness.

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it plans to release second quarter 2019 financial results before the open of the market on Tuesday, August 6, 2019.

Leading European life sciences investment firm Medicxi today announces the closing of Medicxi III, a new €400 million fund.

Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announces that it has completed enrollment in its phase 3 trial evaluating arimoclomol for the treatment of Amyotrophic Lateral Sclerosis (ALS) ahead of schedule.

Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, today reported initial positive data from a subset of patients in the company’s INFRONT clinical study of its product candidate, AL001. AL001 is being evaluated for the treatment of patients with frontotemporal dementia with a granulin mutation (FTD-GRN).

First Biosimilar Avastin® and Herceptin® Products to Launch in the United States

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will participate in training delivered by St. John Ambulance (BC and Yukon) and announce federal funding to address the opioid overdose crisis.

The bone cement market in US is expected to post a CAGR of more than 6% during the period 2019-2023, according to the latest market research report by Technavio.